Key result
AI-enabled 12-lead ECG detects LV systolic dysfunction with an AUROC of 0.88.
Why the study?
AI-based models show promise for detecting cardiovascular diseases from ECGs, but external validation is lacking for many published algorithms, including an existing LVSD detection model.
Does an AI-based 12-lead ECG algorithm accurately detect left ventricular systolic dysfunction in an external European patient cohort?
Observational (n=31,944)
No
Does an AI-based 12-lead ECG algorithm accurately detect left ventricular systolic dysfunction in an external European patient cohort?
An existing AI-based ECG algorithm demonstrated robust external validity for detecting left ventricular systolic dysfunction, and a high predicted probability was associated with a four-fold increased risk of future LVEF deterioration in patients with initially preserved function.
Supports AI-ECG LVSD screening in routine care; extends prior validation to European cohorts but leaves prospective outcome impact open.
Aims: The diagnostic application of artificial intelligence (AI)-based models to detect cardiovascular diseases from electrocardiograms (ECGs) evolves, and promising results were reported. However, external validation is not available for all published algorithms. The aim of this study was to validate an existing algorithm for the detection of left ventricular systolic dysfunction (LVSD) from 12-lead ECGs. Methods and results: Patients with digitalized data pairs of 12-lead ECGs and echocardiography (at intervals of ≤7 days) were retrospectively selected from the Heart Center Leipzig ECG and electronic medical records databases. A previously developed AI-based model was applied to ECGs and calculated probabilities for LVSD. The area under the receiver operating characteristic curve (AUROC) was computed overall and in cohorts stratified for baseline and ECG characteristics. Repeated echocardiography studies recorded ≥3 months after index diagnostics were used for follow-up (FU) analysis. At baseline, 42 291 ECG-echocardiography pairs were analysed, and AUROC for LVSD detection was 0.88. Sensitivity and specificity were 82% and 77% for the optimal LVSD probability cut-off based on Youden's J. AUROCs were lower in ECG subgroups with tachycardia, atrial fibrillation, and wide QRS complexes. In patients without LVSD at baseline and available FU, model-generated high probability for LVSD was associated with a four-fold increased risk of developing LVSD during FU. Conclusion: We provide the external validation of an existing AI-based ECG-analysing model for the detection of LVSD with robust performance metrics. The association of false positive LVSD screenings at baseline with a deterioration of ventricular function during FU deserves a further evaluation in prospective trials.
No takes yet. Share an insight, caveat, or question.
König et al. (2023) conducted an observational in Left ventricular systolic dysfunction (n=31,944). AI-based algorithm for 12-lead ECG analysis vs. Echocardiography was evaluated on Detection of left ventricular systolic dysfunction (LVEF < 40%) (AUROC 0.88, 95% CI 0.87-0.88). An AI-based algorithm applied to 12-lead ECGs accurately detected left ventricular systolic dysfunction with an AUROC of 0.88, a sensitivity of 82%, and a specificity of 77%.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: